6-amino-1-hydroxyhexane-1,1-diphosphonate and Bone Fractures

6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with Bone Fractures in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (66.67)	29.6817
2010's	1 (16.67)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Bhardwaj, A; Sinha, NK; Swe, KMM	1
Adami, G; Bertoldo, F; Fassio, A; Gatti, D; Idolazzi, L; Orsolini, G; Rossini, M; Viapiana, O	1
Adami, S; Braga, V; Colapietro, F; Fracassi, E; Gatti, D; Rossini, M; Tatò, L	1
Adami, S; Antoniazzi, F; Braga, V; Gatti, D; Prizzi, R; Rossini, M; Tatò, L; Viapiana, O	1
Adami, S; Braga, V; Gatti, D; Lippolis, I; Prizzi, R; Rossini, M; Viapiana, O	1
Adami, S; Antoniazzi, F; Donadi, L; Lauriola, S; Tatò, L; Zamboni, G	1

Reviews

1 review(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Bone Fractures

Article	Year
Treatment for osteoporosis in people with beta-thalassaemia. The Cochrane database of systematic reviews, 2023, 05-09, Volume: 5 Topics: Adult; Alendronate; beta-Thalassemia; Child; Clodronic Acid; Denosumab; Diphosphonates; Female; Fractures, Bone; Humans; Male; Middle Aged; Osteoporosis; Pamidronate	2023

Trials

4 trial(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Bone Fractures

Article	Year
Intravenous neridronate in adults with osteogenesis imperfecta. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2003, Volume: 18, Issue:1 Topics: Adult; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Collagen; Collagen Type I; Diphosphonates; Female; Fractures, Bone; Humans; Infusions, Intravenous; Male; Middle Aged; Osteogenesis Imperfecta; Peptides	2003
Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2005, Volume: 20, Issue:5 Topics: Alkaline Phosphatase; Body Height; Bone and Bones; Bone Density; Child; Diphosphonates; Female; Fractures, Bone; Humans; Infusions, Intravenous; Male; Osteogenesis Imperfecta; Prospective Studies; Risk; Time Factors	2005
Intravenous bisphosphonate therapy increases radial width in adults with osteogenesis imperfecta. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2005, Volume: 20, Issue:8 Topics: Absorptiometry, Photon; Adult; Bone and Bones; Bone Density; Calcium; Diphosphonates; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Injections, Intravenous; Male; Osteogenesis Imperfecta; Radius; Tomography, X-Ray Computed; Vitamin D	2005
Early bisphosphonate treatment in infants with severe osteogenesis imperfecta. The Journal of pediatrics, 2006, Volume: 149, Issue:2 Topics: Absorptiometry, Photon; Anthropometry; Calcium; Diphosphonates; Drug Administration Schedule; Early Diagnosis; Female; Follow-Up Studies; Fractures, Bone; Humans; Incidence; Infant; Infant, Newborn; Lumbar Vertebrae; Male; Osteocalcin; Osteogenesis Imperfecta; Phosphates; Prevalence; Prospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome	2006

Other Studies

1 other study(ies) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Bone Fractures

Article	Year
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study. Calcified tissue international, 2017, Volume: 100, Issue:4 Topics: Absorptiometry, Photon; Alkaline Phosphatase; Bone and Bones; Bone Density; Diphosphonates; Female; Fractures, Bone; Humans; Italy; Male; Osteogenesis Imperfecta; Time; Treatment Outcome	2017